Filgrastim (G-CSF) ameliorates Parkinsonism L-dopa therapy's drawbacks in mice

  • Rasha El-Esawy
  • , Mohamed Balaha
  • , Samah Kandeel
  • , Sabeha Hadya
  • , Mohamed Nabih Abd El-Rahman

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Filgrastim (G-CSF) ameliorates Parkinsonism L-dopa therapy's drawbacks in mice'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science